Genetically engineered pig kidney transplantation in a brain‐dead human subject
- 20 November 2021
- journal article
- editorial
- Published by Wiley in Xenotransplantation
- Vol. 28 (6), e12718
- https://doi.org/10.1111/xen.12718
Abstract
In September 2021, a kidney (with donor-specific thymic tissue) from an α1, 3-galactosyltransferase gene-knockout (GTKO) pig was transplanted into the groin (with anastomoses to the femoral vessels) of a brain-dead subject by a surgical team at New York University Langone Health (NYU). It was reported to function immediately, passing urine and excreting creatinine. The experiment was terminated after 54 h and, during this period, the kidney did not show macroscopic features of rejection. Does this experiment provide information not available to us previously and does it move the field forward to clinical trials? The information provided was very limited, but the following points are worthy of note. (i) Numerous in vivo studies in nonhuman primates have predicted that the pig kidney would function immediately. (ii) Numerous in vitro studies have predicted that a GTKO pig kidney would not be rejected within the first few days after transplantation into a human subject. (iii) GTKO kidneys are not optimal for clinical transplantation, and the transplantation of a triple-knockout (TKO) pig kidney would have been more relevant. (iv) There was no purpose in transplanting a “thymokidney” without pre-transplant conditioning therapy and follow-up for several months. (v) Because the native kidneys were retained, it is difficult to determine whether the function of the graft was sufficient to support life. (vi) The experiment was announced to the media rather than published in a peer-reviewed medical journal (although hopefully this will follow), suggesting that it was primarily carried out to gain attention to the great potential of xenotransplantation (and/or possibly to NYU). In this respect the experiment was successful. Because of the very limited period of time for which a brain-dead subject can be maintained in a metabolically and hemodynamically stable state, the value of experiments in such subjects will remain very limited. It is hoped that any future similar experiments will be planned to be more relevant to the clinical situation. Nevertheless, the report has stimulated public attention towards xenotransplantation which, unless there is an adverse response to what some might consider to be a bizarre experiment, should be of significant benefit to future progress.Keywords
This publication has 20 references indexed in Scilit:
- Co-transplantation of Vascularized Thymic Graft with Kidney in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic BarriersPublished by Springer Science and Business Media LLC ,2020
- Meta‐analysis of public perception toward xenotransplantationXenotransplantation, 2020
- Jewish, Christian and Muslim theological perspectives about xenotransplantationXenotransplantation, 2018
- Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout PigsTransplantation, 2017
- Evaluation of human and non‐human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genesXenotransplantation, 2015
- Systemic inflammation in xenograft recipients precedes activation of coagulationXenotransplantation, 2014
- The Inflammatory Response to Brain DeathPublished by Springer Science and Business Media LLC ,2012
- The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart.1989
- CHANGE FROM AEROBIC TO ANAEROBIC METABOLISM AFTER BRAIN DEATH, AND REVERSAL FOLLOWING TRIIODOTHYRONINE THERAPYTransplantation, 1988
- Yu. Yu. Voronoy and the first human kidney allograft.1984